pre-IPO PHARMA

third-pole-therapeutics PRESS RELEASE ARCHIVE

Feb 3, 2022

Third Pole Therapeutics Closes $25M Financing - eNOfit™ Wearable Device Now Ready for Clinical Trials


Apr 15, 2021

Third Pole Therapeutics Secures $15 Million Debt Facility with Avenue Venture Opportunities Fund, L.P.


Feb 24, 2021

Third Pole Therapeutics Expands Board of Directors


Apr 8, 2020

Third Pole Therapeutics Announces Global Commercialization Agreement with Chiesi Group for Its Tankless, Portable Inhaled Nitric Oxide (iNO) Delivery System


Dec 20, 2019

Third Pole Therapeutics To Present at Biotech Showcase 2020



Oct 30, 2019

Third Pole Therapeutics Names Bill Athenson New CEO


Aug 21, 2019

Third Pole Therapeutics Issued New U.S. Patents


Mar 26, 2019

Third Pole Therapeutics Announces Inhaled Nitric Oxide Strategic Collaboration with Actelion, a Janssen Pharmaceutical Company of Johnson and Johnson


Google Analytics Alternative